Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective of this study is to assess, relative to placebo, the efficacy, tolerability, and safety of teplizumab when administered according to 3 different teplizumab dosing regimens in subjects with recent-onset (onset within the past 12 weeks) type 1 diabetes. All regimens will be administered in addition to standard of care.
Critère d'inclusion
- Recent-onset type I diabetes mellitus (T1DM)